Cargando…

A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease

Inflammation in the brain plays a major role in neurodegenerative diseases. In particular, microglial cell activation is believed to be associated with the pathogenesis of neurodegenerative diseases, including Parkinson’s disease (PD). An increase in microglia activation has been shown in the substa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pabon, Mibel M., Jernberg, Jennifer N., Morganti, Josh, Contreras, Jessika, Hudson, Charles E., Klein, Ronald L., Bickford, Paula C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445455/ https://www.ncbi.nlm.nih.gov/pubmed/23028885 http://dx.doi.org/10.1371/journal.pone.0045256

Ejemplares similares

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
por: Pabon, Mibel M, et al.
Publicado: (2011)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
por: Subbarayan, Meena S., et al.
Publicado: (2020)

Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
por: Grimmig, Bethany, et al.
Publicado: (2016)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

Delta Opioid Receptor and Its Peptide: A Receptor-Ligand Neuroprotection
por: Staples, Meaghan, et al.
Publicado: (2013)

Erratum to: Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I., et al.
Publicado: (2015)

Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease
por: Shahaduzzaman, Md, et al.
Publicado: (2015)

Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain
por: Bachstetter, Adam D, et al.
Publicado: (2008)

Spirulina Promotes Stem Cell Genesis and Protects against LPS Induced Declines in Neural Stem Cell Proliferation
por: Bachstetter, Adam D., et al.
Publicado: (2010)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018)

Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease
por: Das, Sabya Sachi, et al.
Publicado: (2023)

Maternal Protein Malnutrition: Current and Future Perspectives of Spirulina Supplementation in Neuroprotection
por: Sinha, Shrstha, et al.
Publicado: (2018)

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
por: Bido, Simone, et al.
Publicado: (2017)

Exploring the Neuroprotective Effects of Spirulina platensis: Insights Into Hemorrhagic Volume and Histological Outcomes
por: Almeida, Timoteo, et al.
Publicado: (2023)

Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
por: Kaneko, Yuji, et al.
Publicado: (2012)

Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α‐synuclein Parkinson's disease rat model
por: Musacchio, Thomas, et al.
Publicado: (2017)

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease
por: Palmas, Maria Francesca, et al.
Publicado: (2022)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Supplementation of Diets With Spirulina Influences Immune and Gut Function in Dogs
por: Satyaraj, Ebenezer, et al.
Publicado: (2021)

Octopamine metabolically reprograms astrocytes to confer neuroprotection against α-synuclein
por: Shum, Andrew, et al.
Publicado: (2023)

Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson’s disease
por: Kumar, Ashutosh, et al.
Publicado: (2016)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson’s disease
por: Leem, Yea-Hyun, et al.
Publicado: (2023)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

Potency of spirulina (Spirulina platensis) on arsenic-induced lipid peroxidation in rat
por: Khair, Abul, et al.
Publicado: (2021)

Microbiota and Cyanotoxin Content of Retail Spirulina Supplements and Spirulina Supplemented Foods
por: Rhoades, Jonathan, et al.
Publicado: (2023)

Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection via Activation of Immunoproteasome
por: Zhou, Hefeng, et al.
Publicado: (2019)

Copper(II) Binding to α-Synuclein, the Parkinson’s Protein
por: Lee, Jennifer C., et al.
Publicado: (2008)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0uefa3r9qdr99l699ufm3kvtff